When will Metoprolol Succinate Tablet, Extended Release be back in stock?

The FDA lists an estimated recovery date per manufacturer where known; check the FDA note column below. National FDA records do not reflect your local pharmacy's shelf.

How do I get an alert when Metoprolol Succinate Tablet, Extended Release changes?

Sign up for a change-only email alert on this page, or subscribe to the RSS or JSON feed. You are notified only when the FDA record changes.

← all medications

Metoprolol Succinate Tablet, Extended Release

Brand names: Metoprolol Succinate

Category: Cardiovascular

Not specified 7

FDA status: To Be Discontinued · Last FDA update: Aug 31, 2026 · First posted: Aug 31, 2026 · 1 manufacturers, 7 listed presentations

As of Aug 31, 2026, the FDA lists Metoprolol Succinate Tablet, Extended Release as being discontinued. Of 7 manufacturer presentations, 7 Not specified.

Ask your pharmacist: which of the 1 manufacturers below can they order right now, and whether a different strength or form of Metoprolol Succinate Tablet, Extended Release is available. For alternatives, talk to your prescriber — see what to do if your medication is in shortage.

Presentation & package NDC	Manufacturer	Availability	FDA note
Metoprolol Succinate, Tablet, Extended Release, 25 mg (NDC 45963-709-96) NDC 45963-709-96	Teva Pharmaceuticals USA, Inc.	Not specified	A business decision was made to discontinue manufacture of the drug.
Metoprolol Succinate, Tablet, Extended Release, 25 mg (NDC 45963-709-11) NDC 45963-709-11	Teva Pharmaceuticals USA, Inc.	Not specified	A business decision was made to discontinue manufacture of the drug.
Metoprolol Succinate, Tablet, Extended Release, 50 mg (NDC 45963-676-11) NDC 45963-676-11	Teva Pharmaceuticals USA, Inc.	Not specified	A business decision was made to discontinue manufacture of the drug.
Metoprolol Succinate, Tablet, Extended Release, 50 mg (NDC 45963-676-96) NDC 45963-676-96	Teva Pharmaceuticals USA, Inc.	Not specified	A business decision was made to discontinue manufacture of the drug.
Metoprolol Succinate, Tablet, Extended Release, 100 mg (NDC 45963-677-11) NDC 45963-677-11	Teva Pharmaceuticals USA, Inc.	Not specified	A business decision was made to discontinue manufacture of the drug.
Metoprolol Succinate, Tablet, Extended Release, 100 mg (NDC 45963-677-96) NDC 45963-677-96	Teva Pharmaceuticals USA, Inc.	Not specified	A business decision was made to discontinue manufacture of the drug.
Metoprolol Succinate, Tablet, Extended Release, 200 mg (NDC 45963-678-11) NDC 45963-678-11	Teva Pharmaceuticals USA, Inc.	Not specified	A business decision was made to discontinue manufacture of the drug.

Related medications in shortage

Other Cardiovascular medications currently on the FDA shortage list — useful context if you and your prescriber are weighing alternatives. Always confirm with your pharmacist.

Change log

No changes recorded yet.
Tracking began Oct 1, 2026. We check the FDA every 6 hours; any real change - a manufacturer moving from Limited to Available, a new recovery date, a new listing - shows up here with its date.

Cite this: “FDA drug-shortage status for Metoprolol Succinate Tablet, Extended Release (FDA data as of Aug 31, 2026). Shortage Watch, openFDA.”

Get an email when this record changes

One email, only when the FDA changes something for Metoprolol Succinate Tablet, Extended Release. You confirm by clicking a link first (double opt-in). No newsletter, no other mail.

Check your inbox - click the confirmation link to activate alerts for Metoprolol Succinate Tablet, Extended Release.

Feeds instead of email: RSS or JSON. Unsubscribe anytime; see Privacy.

Embed a live status badge: /badge/metoprolol-succinate-tablet-extended-release.svg

FDA data last synced Oct 1, 2026 (FDA record dated Sep 30, 2026).